Nivea
Nivea Body Q10 Multi Power 4 In 1 Cream
Nivea q10 multi power 4in1 firming legs, bums & tums cream has been enriched with soy extract and q10. This special zone product firms the skin within 2 weeks, leaving it moisturised for over 24 hours. With regular use, your skin elasticity will be supported. The skin compatibility has been dermatologically approved.
2
Bien
12
Neutre
0
Mise en garde
6
Éviter
10% bien
60% neutre
0% mise en garde
30% éviter
Survolez une ligne · cliquez pour la carte
Water
Aqua
solvent
→
Glycerin
Glycerol
denaturant hair conditioning humectant oral care perfuming skin conditioning skin protecting solvent viscosity controlling
→
Paraffinum Liquidum
Mineral Oil
antistatic emollient skin protecting solvent
→
Cetyl Alcohol
emollient emulsifying emulsion stabilising foam boosting masking opacifying surfactant viscosity controlling
→
Caprylic/Capric Triglyceride
masking perfuming skin conditioning
→
Cetearyl Isononanoate
emollient hair conditioning skin conditioning
→
Alcohol Denat.
antifoaming antimicrobial astringent masking solvent viscosity controlling
→
Dimethicone
Glyceryl Stearate
emollient emulsifying
→
PEG-40 Stearate
emulsifying surfactant
→
Ubiquinone
Coenzyme Q10
antioxidant skin conditioning
→
Glycine Soja Germ Extract
emollient skin conditioning
→
Sodium Carbomer
emulsion stabilising film forming gel forming viscosity controlling
→
Phenoxyethanol
preservative
→
Linalool
deodorant perfuming
→
Citronellol
perfuming
→
Alpha-Isomethyl Ionone
perfuming skin conditioning
→
Benzyl Alcohol
perfuming preservative solvent viscosity controlling
→
Limonene
deodorant perfuming solvent
→
Coumarin
perfuming
→
Состав
Water, Glycerin, Paraffinum Liquidum, Cetyl Alcohol, Caprylic/Capric Triglyceride, Cetearyl Isononanoate, Alcohol Denat., Dimethicone, Glyceryl Stearate, PEG-40 Stearate, Ubiquinone, Glycine Soja Germ Extract, Sodium Carbomer, Phenoxyethanol, Linalool, Citronellol, Alpha-Isomethyl Ionone, Benzyl Alcohol, Limonene, Coumarin
Trouver des produits similaires…
L'historique des modifications n'est pas encore suivi